ESTRACYT 140 mg, hard capsule 100 capsules
Active ingredients: Estramustine phosphate, Estramustine phosphate sodium monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule100 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ESTRACYT 140 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 100 gélule(s)
- Marketing authorisation holder
- ESTEVE PHARMACEUTICALS
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60675618CIP73229795CIP133400932297955Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE DISODIQUE D'ESTRAMUSTINE MONOHYDRATÉgélule | 156,7 mg · une gélule | SA |
| ESTRAMUSTINE PHOSPHATEgélule | 140 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.